Strengthening research and science leadership capacity of African researchers
The call is endorsed by a global coalition advocating for a fully funded and resourced TB vaccine pipeline by 2023
IAVI and African Vaccine Manufacturing Initiative host virtual forum
Nkengasong was a founding leader of PEPFAR and has served on IAVI’s board since 2018.
Janssen-sponsored trial in sub-Saharan Africa discontinued due to lack of efficacy.
New leadership program positions homegrown scientists to drive research into HIV and other infectious diseases in Africa and India.
Vaccine candidate targets vulnerabilities common across many HIV-1 variants.
A Q&A with Dr. Gagandeep Kang, professor of microbiology at the Wellcome Trust Research Laboratory, held on May 12, 2021, and co-organized by IAVI...
A commentary by Mark Feinberg, M.D., Ph.D., IAVI president and CEO
IAVI’s Dr. Jayanta Bhattacharya, of the Translational Health Science and Technology Institute, India, is interviewed by DBT/Wellcome Trust India All...